Angiogenesis, the formation of new blood vessels, plays a crucial role in tumor growth and metastasis. Antiangiogenic therapy has emerged as a promising strategy to impede tumor progression by targeting tumor vasculature. While traditional antiangiogenic agents have shown efficacy in certain cancers, their limitations, such as drug resistance and adverse effects, highlight the need for novel approaches. This article explores recent advancements in targeting tumor vasculature, including innovative therapeutic modalities and combination strategies, aiming to enhance treatment outcomes and overcome existing challenges in antiangiogenic therapy.
HTML PDFShare this article
Journal of Oncology Translational Research received 93 citations as per Google Scholar report